期刊
CURRENT PHARMACEUTICAL DESIGN
卷 17, 期 26, 页码 2803-2807出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161211797440131
关键词
multiple sclerosis; HIV-associated neurocognitive disorders; mitoxantrone; experimental autoimmune encephalomyelitis
资金
- German Ministry for Education and Research (BMBF, German Competence Network Multiple Sclerosis (KKNMS, CONTROL MS) [01GI0914]
Owing to therapeutic progress, the role of ABC-transporters in infectious and autoimmune inflammatory CNS-diseases has recently gained considerable attention. In HIV-encephalitis and HIV-associated neurocognitive disorders, ABC-transporters are discussed to contribute to limited CNS-penetration and -retention of antiviral agents. In multiple sclerosis and its animal model experimental autoimmune encephalomyelitis, ABC-transporters may be involved in pathogenesis and treatment response alike. A prospective pharmacogenetic study is currently underway to examine the predictive role of genetic variations in ABC-transporters for treatment response and adverse events to mitoxantrone, a therapeutic agent used in aggressive MS. These approaches may aid in individualized treatment with this cytostatic anthracenedione, addressing its narrow therapeutic index with potentially fatal side effects. Finally, understanding regulation and function of ABC-transporters under inflammatory conditions may also optimize ABC-transporter-related treatment strategies in other neurological diseases (e. g. neurodegenerative, and neurovascular) where neuroinflammatory mechanisms have gained considerable attention as important contributors to pathogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据